BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 23377517)

  • 1. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
    Stockfleth E
    J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of actinic keratosis.
    Berman B; Amini S; Valins W; Block S
    Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
    Bettencourt MS
    J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical findings using ingenol mebutate gel to treat actinic keratoses.
    Martin G; Swanson N
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S39-48. PubMed ID: 23228305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing management of actinic keratosis and photodamaged skin: utilizing a stepwise approach.
    Lee AD; Jorizzo JL
    Cutis; 2009 Sep; 84(3):169-75. PubMed ID: 19842577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of actinic keratosis: an update.
    Berman B; Amini S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of treating the field in actinic keratosis.
    Stockfleth E
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():8-11. PubMed ID: 28263021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
    Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
    Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of actinic keratoses.
    Shoimer I; Rosen N; Muhn C
    Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review.
    Jetter N; Chandan N; Wang S; Tsoukas M
    Am J Clin Dermatol; 2018 Aug; 19(4):543-557. PubMed ID: 29582369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of topical interventions for the treatment of actinic keratosis.
    Koch EAT; Wessely A; Steeb T; Berking C; Heppt MV
    Expert Opin Drug Saf; 2021 Jul; 20(7):801-814. PubMed ID: 33834933
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment considerations in actinic keratosis.
    Goldenberg G
    J Eur Acad Dermatol Venereol; 2017 Mar; 31 Suppl 2():12-16. PubMed ID: 28263018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: Commonly used field-directed and lesion-directed therapies.
    Berman B; Cohen DE; Amini S
    Cutis; 2012 Jun; 89(6):294-301. PubMed ID: 22838095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
    Philipp-Dormston WG
    Curr Probl Dermatol; 2015; 46():115-21. PubMed ID: 25561215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ingenol mebutate-mediated reduction in p53-positive keratinocytes in skin cancerization field directly correlates with clinical response in patients with multiple actinic keratoses.
    Grandi V; di Gennaro P; Torrigiani S; Basco L; Lastrucci I; Pimpinelli N
    J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1297-1303. PubMed ID: 30801837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining field therapies for actinic keratoses: novel approaches that intensify photodynamic therapy.
    Kaminska EC; Tsoukas MM
    Skinmed; 2013; 11(1):54-8. PubMed ID: 23540080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.